Q1 FY2027 · ended Jun 30, 2026 · Revenue $60.14M, +1.0% YoY · Filed Aug 10, 2026
Mesa Laboratories Inc /CO (MLAB) files with the SEC under industry code 3823, Industrial Instruments For Measurement, Display, and Control. In Q1 of fiscal 2027, the quarter ended Jun 30, 2026, it reported revenue of $60.1 million and net income of $2.8 million. Free cash flow was $14.2 million. As of Jun 30, 2026 it held $30.7 million in cash and investments and $84.6 million in total debt.
Company profile
- Industry
- Industrial Instruments For Measurement, Display, and Control (SIC 3823)
- Listed as
- MLAB (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- CO
- Headquarters
- Lakewood, CO
- SEC filer status
- Accelerated filer
- SEC CIK
- 724004
- Former names
- MESA LABORATORIES INC /CO (until Aug 28, 2020)
Other Industrial Instruments For Measurement, Display, and Control companies
- Danaher Corp /DE/ DHR
- Ametek INC/ AME
- Keysight Technologies, Inc. KEYS
- Roper Technologies Inc ROP
- Fortive Corp FTV
- MKS Inc MKSI
- Cognex Corp CGNX
- Ralliant Corp RAL
All 18 Industrial Instruments For Measurement, Display, and Control companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q1 FY2027 Jun 30, 2026 |
Q1 FY2025 Jun 30, 2025 |
Q4 FY2025 Mar 31, 2025 |
Q3 FY2025 Dec 31, 2024 |
Q2 FY2025 Sep 30, 2024 |
|---|---|---|---|---|---|
| Revenue | $60.1M | $59.5M | $62.1M | $62.8M | $57.8M |
| Operating income | $7.0M | $3.1M | $1.5M | $5.8M | $3.5M |
| Net income | $2.8M | $4.7M | -$7.1M | -$1.7M | $3.4M |
| Diluted EPS | $0.49 | $0.85 | -$1.34 | -$0.31 | $0.63 |
| Operating cash flow | $14.7M | $1.9M | $12.7M | $18.1M | $14.1M |
| Free cash flow | $14.2M | $884,000 | $11.9M | $17.3M | $12.5M |
| Total assets | $419.2M | $435.7M | $433.3M | $433.3M | $454.1M |
| Total liabilities | $230.5M | $263.2M | $273.5M | $273.5M | $292.6M |
| Stockholders' equity | $188.8M | $172.5M | $159.8M | $155.2M | $161.5M |
| Cash and investments | $30.7M | $21.3M | $27.3M | $27.3M | $24.3M |
| Total debt | $84.6M | $74.1M | $87.2M | $75.7M | $76.6M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure
|
Oct 13, 2026 | Oct 12, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Sep 8, 2026 | Sep 8, 2026 |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K | Current report | Jul 30, 2026 | Jul 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 15, 2026 | Jun 11, 2026 |
All 1005 Mesa Laboratories Inc /CO SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.